Calumet Specialty Company Insiders
CLMT Stock | USD 22.40 0.24 1.08% |
Calumet Specialty's insiders are aggressively selling. The current insiders' sentiment regarding investing in Calumet Specialty Products stock implies that vertually all insiders are panicking. Calumet Specialty employs about 1.6 K people. The company is managed by 12 executives with a total tenure of roughly 16 years, averaging almost 1.0 years of service per executive, having 131.67 employees per reported executive.
Bruce Fleming President Executive Vice President - Strategy and Growth of Calumet GP, LLC |
Calumet Specialty's Insider Buying Vs Selling
0
Selling | Buying |
Latest Trades
2024-11-12 | Jennifer Straumins | Disposed 100000 @ 20.59 | View | ||
2024-05-15 | Gregory J Morical | Disposed 11111 @ 15.04 | View | ||
2024-01-18 | Stephen P Mawer | Disposed 15037 @ 17.87 | View |
Monitoring Calumet Specialty's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Calumet |
Calumet Specialty's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Calumet Specialty's future performance. Based on our forecasts, it is anticipated that Calumet will maintain a workforce of slightly above 1580 employees by December 2024.Calumet Specialty Management Team Effectiveness
The company has return on total asset (ROA) of 0.0167 % which means that it generated a profit of $0.0167 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (11.7222) %, meaning that it created substantial loss on money invested by shareholders. Calumet Specialty's management efficiency ratios could be used to measure how well Calumet Specialty manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Calumet Specialty's Return On Tangible Assets are comparatively stable compared to the past year. Return On Capital Employed is likely to gain to 0.17 in 2024, despite the fact that Return On Equity is likely to grow to (0.09). At this time, Calumet Specialty's Total Current Liabilities is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 79.1 M in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 1.8 B in 2024.Common Stock Shares Outstanding is likely to drop to about 52.4 M in 2024. Net Loss is likely to gain to about (141.2 M) in 2024
Calumet Specialty Workforce Comparison
Calumet Specialty Products is number one stock in number of employees category among its peers. The total workforce of Energy industry is currently estimated at about 3,612. Calumet Specialty totals roughly 1,580 in number of employees claiming about 44% of equities under Energy industry.
Calumet Specialty Profit Margins
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.04) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.04.Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Gross Profit Margin | 0.11 | 0.108 |
|
|
Calumet Specialty Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Calumet Specialty insiders, such as employees or executives, is commonly permitted as long as it does not rely on Calumet Specialty's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Calumet Specialty insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-12-01 | 8.5 | 17 | 2 | 55,011 | 200,000 |
2024-06-01 | 1.4286 | 10 | 7 | 286,689 | 437,978 |
2024-03-01 | 1.1429 | 16 | 14 | 202,088 | 281,406 |
2023-12-01 | 9.3333 | 28 | 3 | 119,551 | 11,639 |
2023-09-01 | 7.5 | 15 | 2 | 327,486 | 14,260 |
2023-06-01 | 3.25 | 13 | 4 | 118,056 | 148,408 |
2023-03-01 | 3.0909 | 34 | 11 | 705,990 | 581,436 |
2022-09-01 | 19.0 | 19 | 1 | 35,347 | 2,428 |
2022-06-01 | 1.1667 | 7 | 6 | 52,055 | 112,591 |
2022-03-01 | 3.125 | 25 | 8 | 647,503 | 79,414 |
2021-03-01 | 2.5 | 50 | 20 | 785,556 | 397,183 |
2020-12-01 | 4.75 | 19 | 4 | 202,880 | 7,222 |
2020-09-01 | 3.0 | 12 | 4 | 73,818 | 374,641 |
2020-06-01 | 14.0 | 14 | 1 | 166,355 | 50,000 |
2020-03-01 | 1.925 | 77 | 40 | 1,180,722 | 665,514 |
2019-03-01 | 1.0 | 42 | 42 | 446,866 | 285,380 |
2018-12-01 | 3.5556 | 32 | 9 | 334,507 | 42,609 |
2018-06-01 | 0.875 | 21 | 24 | 139,554 | 164,072 |
2018-03-01 | 2.6154 | 34 | 13 | 432,886 | 34,356 |
2017-12-01 | 3.2 | 16 | 5 | 114,248 | 99,691 |
2017-03-01 | 1.3111 | 59 | 45 | 1,185,811 | 411,148 |
2016-09-01 | 8.0 | 16 | 2 | 52,585 | 153.00 |
2016-06-01 | 1.6122 | 79 | 49 | 778,108 | 338,069 |
2016-03-01 | 22.5 | 45 | 2 | 44,160 | 20,526 |
2015-09-01 | 13.6667 | 41 | 3 | 6,409 | 199.00 |
2015-03-01 | 1.5588 | 53 | 34 | 113,120 | 66,959 |
2014-12-01 | 22.0 | 44 | 2 | 15,436 | 16,200 |
2014-09-01 | 6.0 | 54 | 9 | 252,716 | 967,246 |
2014-03-01 | 1.913 | 88 | 46 | 34,558 | 266,116 |
2013-12-01 | 1.3784 | 102 | 74 | 89,519 | 70,304 |
2013-09-01 | 1.746 | 110 | 63 | 20,870 | 12,040 |
2013-06-01 | 2.6 | 78 | 30 | 8,497 | 3,789 |
2013-03-01 | 1.9231 | 100 | 52 | 151,261 | 63,800 |
2012-12-01 | 1.5172 | 132 | 87 | 80,817 | 61,681 |
2012-09-01 | 1.8615 | 121 | 65 | 18,191 | 10,897 |
2012-06-01 | 2.625 | 105 | 40 | 1,300,423 | 5,124,917 |
2012-03-01 | 1.9219 | 123 | 64 | 262,866 | 86,435 |
2011-12-01 | 1.7353 | 118 | 68 | 128,910 | 27,875 |
2011-09-01 | 2.1961 | 112 | 51 | 89,672 | 7,570 |
2011-06-01 | 3.0357 | 85 | 28 | 11,376 | 4,858 |
2011-03-01 | 2.2419 | 139 | 62 | 39,382,019 | 18,705,606 |
2010-12-01 | 1.9787 | 93 | 47 | 36,434 | 15,612 |
2009-12-01 | 6.7778 | 61 | 9 | 45,310 | 7,853 |
2009-09-01 | 12.0 | 24 | 2 | 4,996 | 6,000 |
2009-03-01 | 11.5 | 23 | 2 | 1,224,434 | 1,200,000 |
2008-06-01 | 119.8 | 599 | 5 | 622,100 | 1,437,650 |
2008-03-01 | 1.0 | 1 | 1 | 1,500 | 3,000 |
2007-12-01 | 1.0 | 14 | 14 | 11,072 | 4,018 |
2007-06-01 | 0.2 | 1 | 5 | 500.00 | 1,935,787 |
2007-03-01 | 9.0 | 9 | 1 | 101,175 | 2,250 |
2006-12-01 | 2.1667 | 13 | 6 | 9,420 | 1,824 |
2006-03-01 | 13.0 | 39 | 3 | 47,433,420 | 0.00 |
Calumet Specialty Notable Stakeholders
A Calumet Specialty stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Calumet Specialty often face trade-offs trying to please all of them. Calumet Specialty's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Calumet Specialty's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Louis Borgmann | CEO President | Profile | |
Bruce Fleming | Executive Vice President - Strategy and Growth of Calumet GP, LLC | Profile | |
David Lunin | Executive CFO | Profile | |
Stephen Mawer | Independent Director of Calumet GP, LLC | Profile | |
John Kompa | Director Relations | Profile | |
Gregory Morical | General VP | Profile | |
Chris Hodges | Alpha IR | Profile | |
Marc Lawn | LLC GP | Profile | |
Vincent Donargo | Chief Officer | Profile | |
Brad McMurray | Director Relations | Profile | |
Scott Obermeier | LLC GP | Profile | |
Ryan Willman | LLC GP | Profile |
About Calumet Specialty Management Performance
The success or failure of an entity such as Calumet Specialty often depends on how effective the management is. Calumet Specialty management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Calumet management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Calumet management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.02 | 0.02 | |
Return On Capital Employed | 0.16 | 0.17 | |
Return On Assets | 0.02 | 0.02 | |
Return On Equity | (0.10) | (0.09) |
Please note, the imprecision that can be found in Calumet Specialty's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Calumet Specialty Products. Check Calumet Specialty's Beneish M Score to see the likelihood of Calumet Specialty's management manipulating its earnings.
Calumet Specialty Workforce Analysis
Traditionally, organizations such as Calumet Specialty use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Calumet Specialty within its industry.Calumet Specialty Manpower Efficiency
Return on Calumet Specialty Manpower
Revenue Per Employee | 2.6M | |
Revenue Per Executive | 348.4M | |
Net Income Per Employee | 29.8K | |
Net Income Per Executive | 3.9M |
Additional Tools for Calumet Stock Analysis
When running Calumet Specialty's price analysis, check to measure Calumet Specialty's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Calumet Specialty is operating at the current time. Most of Calumet Specialty's value examination focuses on studying past and present price action to predict the probability of Calumet Specialty's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Calumet Specialty's price. Additionally, you may evaluate how the addition of Calumet Specialty to your portfolios can decrease your overall portfolio volatility.